youtube_live
Q3 2026 earnings • released • EPS beat +8.82% • Revenue beat +3.25%
See resultschevron_right
NOVN:SWX
Novartis AG
CHF 132.30
arrow_upward
+2.38%(+3.08) 1D
Oct 29, 5:30:41 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 130.76
High
CHF 134.36
Low
CHF 130.12
Mkt. cap
268.85B
Avg. vol.
3.28M
Volume
6.12M
Dividend
2.80%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
24.10
52-wk high
CHF 134.36
52-wk low
CHF 97.05
EPS
CHF 5.49
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 130.76
High
CHF 134.36
Low
CHF 130.12
Mkt. cap
268.85B
Avg. vol.
3.28M
Volume
6.12M
Dividend
2.80%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
24.10
52-wk high
CHF 134.36
52-wk low
CHF 97.05
EPS
CHF 5.49
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
www.marketscreener.com
·
26 minutes ago
Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge
Seeking Alpha
·
5 hours ago
Novartis AG 2026 Q3 - Results - Earnings Call Presentation (NYSE:NVS) 2026-10-29
TradingView
·
1 day ago
What Novartis (NVS) Said on Its Q3 Earnings Call
Yahoo Finance
·
1 day ago
Novartis AG (NVS) (Q3 2026) Earnings Call Highlights: Raised Guidance and Priority Brand ...
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com